Ionis Pharmaceuticals IONS Changes in unrecognized tax benefits
Changes in unrecognized tax benefits at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxContingencies.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's changes in unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's changes in unrecognized tax benefits?
- Ionis Pharmaceuticals (IONS) reported changes in unrecognized tax benefits of $3.04M in Q4 2025.
- What does changes in unrecognized tax benefits mean?
- The financial impact of reserves for uncertain tax positions.
- How do you interpret changes in unrecognized tax benefits?
- Increases suggest higher uncertainty or potential future tax liabilities from audits.
- How does changes in unrecognized tax benefits compare across companies?
- Standard disclosure required under accounting standards for tax contingencies.